Skip to Main Content

Collaborating Institutions, Centers, and Programs

Aaron Diamond AIDS Research Center

Aaron Diamond AIDS Research CenterThe Aaron Diamond AIDS Research Center focuses on the basic science of AIDS and HIV in a research environment conducive to the highest level of scientific creativity. ADARC's scientific director, Rockefeller professor David D. Ho, is a former Time magazine Man of the Year who developed the now-standard HIV "cocktail therapy" at The Rockefeller University Hospital.


Clinical Directors Network

Clinical Directors NetworkAs part of a commitment to community engagement, the Rockefeller University Center for Clinical and Translational Science developed a partnership with the Clinical Directors Network (CDN) in 2007. CDN is a non-profit practice-based research network (PBRN) and clinician training organization that works with community-based, safety-net primary care health centers throughout the United States, working in close partnership with academic institutions, governmental agencies and non-governmental organizations. CDN is dedicated to providing and improving comprehensive and accessible community-oriented primary and preventive health care services for the poor, minority and underserved populations, with an overall goal of the translation of clinical research into clinical practice to increase health equity. Since 1992, nearly 55,000 patients have participated in randomized controlled trials and observational studies conducted by CDN, of whom 49% were African American and 34% were Latino/a. CDN has also developed a state-of-the-art online network to support CME-accredited educational training via live interactive webcasts for physicians and other clinicians, public health and health care administrators. CDN maintains an web-based course library with nearly 500 on-demand classes accredited for physicians, dentists, pharmacists, nurses and mental health professionals. In 2006, CDN was recognized as a "best practice" clinical research network by the NIH Roadmap initiative.

Click here for additional information.

The Rogosin Institute

Rogosin InstituteThe Rogosin Institute is a not-for-profit institution for medical research and treatment in kidney disease (including dialysis and transplantation) and cardiovascular disease related to cholesterol and other lipid abnormalities. The Rogosin Institute also has extensive research programs in diabetes, cancer, endotoxemia and telemedicine.


SMART (Students Modeling A Research Topic) Program

The SMART (Students Modeling A Research Topic) program is run by the Center for Biomolecular Modeling at the Milwaukee School of Engineering (MSOE). SMART Teams are comprised of teachers and groups of middle or high school students working with research scientists to design and construct physical models of molecules that are being investigated by the scientists. The SMART program has partnered with Rockefeller University's Center for Clinical and Translational Science (CCTS) in a new community outreach effort. This program begins with teachers enrolling in a professional development course designed for learning approaches to teaching biomolecular structure and function, as well as how to integrate computer and physical modeling into the classroom curriculum. After completing the course, participating teachers form SMART Teams in their home schools. These teams work with a Rockefeller University faculty member to design and build a physical model of a protein or other molecular structure using the technique of 3-dimensional printing.

Click here for additional information.

Collaborating Rockefeller University Interdisciplinary Centers

Center for the Study of Hepatitis C

New York City's Center for the Study of Hepatitis C, established in 2000 at The Rockefeller University, Weill Medical College of Cornell University and New York- Presbyterian Hospital, is the only comprehensive, multidisciplinary center dedicated to the study of HCV and hepatic disease in the tri-state area. Initial funding was provided by the Greenberg Medical Research Institute. Ongoing research depends heavily on grant support from the National Institutes of Health and private donations.

The unique collaborative environment of the Center allows prominent scientists and dedicated physicians to work together to understand HCV infection, to effectively manage its associated liver disease, and to develop new treatments for HCV-infected patients.

The Center is committed to:

  • Outstanding patient care
  • Clinical trials
  • Clinical research
  • Basic science research
  • Education and outreach

Click here for additional information.

Christopher H. Browne Center for Immunology and Immune Diseases

The Center is comprised of 7 laboratories headed by Drs. Ho, Munz, Nussenzweig, Papavasiliou, Ravetch, Steinman, and Tarakhovsky. These investigators represent several disciplines including oncology, virology, molecular immunology, cellular and developmental immunology, and signal transduction.

Click here for additional information.

F.M. Kirby Center for Sensory Neuroscience

Scientists at the center, under the direction of F.M. Kirby Professor A. James Hudspeth, M.D., Ph.D., an HHMI investigator, pursue studies of vision, hearing, smell and taste, using such tools as molecular genetics, computer science, microscopy and brain imaging.

Click here for additional information.

Fisher Center for Alzheimer's Disease Research

The Center serves as the nexus for Alzheimer's disease research at Rockefeller. It includes state-of-the-art technologies to expand and accelerate Alzheimer's research in the laboratory and patient-oriented studies of physician-scientists at The Rockefeller University Hospital. The Center's investigations build on Alzheimer's studies conducted by Dr. Paul Greengard, the Center director. Much of his laboratory's research focuses on how the cells of the brain process the amyloid precursor protein (APP), a phosphoprotein implicated in the onset of Alzheimer's disease. Another Center member, Dr. Jan Breslow, head of the Laboratory of Biochemical Genetics and Metabolism, discovered the gene for apolipoprotein E, a key protein in cholesterol metabolism recently identified as a risk factor for Alzheimer's. Experimental therapeutics are now being tested in animal models of disease and successful products of this translational Center will be tested in clinical studies within Rockefeller's CTSA.

Click here for additional information.

NIH NIDA-P60 Center, Treatment of Addictions: Biological Correlates

Led by Mary Jeanne Kreek, M.D., Professor, Senior Physician, Head of the Laboratory of the Biology of Addictive Diseases, the center is fully integrated with the clinical research of the Rockefeller University Hospital. This Center from its inception in 1987, an outgrowth of the pioneering work of Kreek with Dole in developing methadone maintenance treatment from 1964 onward, has been developed to perform bidirectional translational research, with interdisciplinary projects and support cores to study the molecular neurobiological and genetic bases of specific addictive diseases, along with related neurochemical, pathological, and behavioral mechanisms involved in addiction.

Shelby White and Leon Levy Center for Mind, Brain and Behavior

Laboratories in the center develop and apply the latest technology to explore questions about the mind and brain that were virtually out of reach just a few years ago. Established in 1998 through the generosity of the late Leon Levy, who was a Rockefeller trustee, the center is a nexus for the work of laboratories studying neural systems, neurogenetics, neural development and neurochemistry. The Leon Levy Foundation continues to provide support for the center's efforts.

Click here for additional information.